Effect of HIV Infection Status and Anti‐Retroviral Treatment on Quantitative and Qualitative Antibody Responses to Pneumococcal Conjugate Vaccine in Infants

This publication has 14 references indexed in Scilit:

• Nasopharyngeal Carriage ofStreptococcus pneumoniaeShortly before Vaccination with a Pneumococcal Conjugate Vaccine Causes Serotype‐Specific Hyporesponsiveness in Early Infancy
  The Journal of Infectious Diseases, 2010
• Early Antiretroviral Therapy and Mortality among HIV-Infected Infants
  New England Journal of Medicine, 2008
• Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies
  Vaccine, 2007
• Gamma Interferon Production in Response toMycobacterium bovisBCG andMycobacterium tuberculosisAntigens in Infants Born to Human Immunodeficiency Virus-Infected Mothers
  Clinical and Vaccine Immunology, 2006
• Quantitative and Qualitative Antibody Response to Pneumococcal Conjugate Vaccine Among African Human Immunodeficiency Virus-Infected and Uninfected Children
  The Pediatric Infectious Disease Journal, 2005
• Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis
  The Lancet, 2004
• Safety and Immunogenicity of a Heptavalent Pneumococcal Conjugate Vaccine in Infants With Human Immunodeficiency Virus Type 1 Infection
  Pediatrics, 2003
• Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach. Executive summary. April 2002.
  2002
• T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV.
  2000
• An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study.
  2000